Validity and responsiveness of Barthel index for measuring functional recovery after hemiarthroplasty for femoral neck fracture

Unnanuntana, Aasis; Jarusriwanna, Atthakorn; Nepal, Sarthak

doi:10.1007/s00402-018-3020-z

Cited by 46 publications

(21 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A higher score (maximum 100) indicates good functional ability and a greater likelihood of being able to live independently at home after discharge from the hospital, and a lower score (minimum 0) indicates poor functional status and likelihood of being dependent on caregiver. This tool has been validated in hip fracture patients [17].…”

Section: Outcome Measurementmentioning

confidence: 99%

High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Hypovitaminosis D can be observed in most fragility hip fracture patients. However, measurement of 25-hydroxyvitamin D (25(OH)D) level is costly and may not be available in some centers. Without the baseline serum 25(OH)D level, the appropriate dose of vitamin D supplementation is not known. The aim of this study was to evaluate the effectiveness and safety of vitamin D supplementation in fragility hip fracture patients compared between high- and low-dose vitamin D supplementation. Methods A total of 140 patients diagnosed with fragility hip fracture were randomly allocated to either the high-dose (60,000 IU/week) or low-dose (20,000 IU/week) vitamin D2 supplementation group for 12 weeks. The number of patients who achieved optimal vitamin D level (serum 25(OH)D > 30 ng/mL), the proportion of patients who developed hypercalcemia, and the functional outcome were compared between groups. Results Of the 140 patients who were enrolled, 21 patients were lost to follow-up during the study period. The remaining 119 patients (58 and 61 in the high- and low-dose groups, respectively) were included in the final analysis. The high-dose group had a higher rate of serum 25(OH)D restoration to optimal level than the low-dose group (82.8% vs 52.5%, respectively; p < 0.001). Approximately 3.4 and 1.6% of patients in the high- and low-dose groups, respectively, had mild transient hypercalcemia, but none developed moderate, severe, or symptomatic hypercalcemia. There were no differences in functional outcome scores between groups. Conclusions In treatment settings where baseline serum 25(OH)D level can’t be evaluated in older adults with fragility hip fracture, we recommend high-dose vitamin D2 of approximately 60,000 IU/week for 12 weeks, with subsequent switch to a maintenance dose. This regimen effectively restored serum vitamin D to an optimal level in 82.8% of patients without causing symptomatic hypercalcemia. Trial registration The protocol of this study was retrospectively registered in the Thai Clinical Trials Registry database no. TCTR20180302007 on 20 February 2018.

show abstract

Section: Outcome Measurementmentioning

confidence: 99%

High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…The BI is an ordinal scale used to measure performance in routine daily activities. It is one of the most commonly used clinical instruments for general assessment of physical function, especially in rehabilitation 23) . Although more specific for neurological diseases, in our and other studies 24) it was used for global functional status evaluation 25) .…”

Section: Participants and Methodsmentioning

confidence: 99%

Use of the pedometer in the evaluation of the effects of rehabilitation treatment on deambulatory autonomy in patients with lower limb arthroplasty during hospital rehabilitation: long-term postoperative outcomes

et al. 2020

View full text Add to dashboard Cite

To provide data on the applicability of pedometers in the evaluation of the results of rehabilitative treatment on total daily walking activity after total knee arthroplasty (TKA) and total hip arthroplasty (THA). [Participants and Methods] One hundred fifty six hospitalized patients (age 63.9 ± 12.2 years) involved. On the day of hospitalization and at the end of the rehabilitation treatment the following were performed: clinical examination, X-ray examination and weight. On the same day the pedometer was applied and removed after 48 hours. Only on 30 participants, the same evaluation was carried out 5 days before the hospitalization to measure reliability and responsiveness. Compliance was measured by a face-to-face interview. Visual analogic scale (VAS), Barthel Index (BI) and Ambulation Index (AI) were used to better describe the analyzed sample. [Results] VAS, BI and AI improved by 29.8%, 19.4 and 60.6% respectively. The data obtained on testing-retesting showed a good reliability and a mean Total Error of 7.3% for steps and 15.8% for distance. A good response in the test-retest was detected. The deambulatory autonomy of patients passed from 2,070 ± 740 m to 3,100 ± 810 m. Average improvement in the number of daily steps is 25%. [Conclusion] The data showed a good applicability of pedometer. The results on responsiveness can be used to better interpret the results of rehabilitative treatment on total daily walking activity after THA and TKA.

show abstract

“…A higher score indicates a greater likelihood of being able to live independently at home after discharge from the hospital. This tool has been validated in hip fracture patients [14]. EQ-VAS is a simple self-evaluated scale that rates health status ranging from 0 to 100 points.…”

Section: Outcome Measurementmentioning

confidence: 99%

High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: A randomized controlled trial

Jarusriwanna

Phusunti

Unnanuntana

2021

Preprint

Self Cite

View full text Add to dashboard Cite

Background: Hypovitaminosis D can be observed in most fragility hip fracture patients. However, measurement of 25-hydroxyvitamin D (25(OH)D) level is costly and may not be available in some centers. Without the baseline serum 25(OH)D level, the appropriate dose of vitamin D supplementation is not known. The aim of this study was to evaluate the effectiveness and safety of vitamin D supplementation in fragility hip fracture patients compared between high- and low-dose vitamin D supplementation. Methods: A total of 140 patients diagnosed with fragility hip fracture were randomly allocated to either the high-dose (60,000 IU/week) or low-dose (20,000 IU/week) vitamin D2 supplementation group for 12 weeks. The number of patients who achieved optimal vitamin D level (serum 25(OH)D > 30 ng/mL), the proportion of patients who developed hypercalcemia, and the functional outcome were compared between groups. Results: Of the 140 patients who were enrolled, 21 patients were lost to follow-up during the study period. The remaining 119 patients (58 and 61 in the high- and low-dose group, respectively) were included in the final analysis. The high-dose group had a higher rate of serum 25(OH)D restoration to optimal level than the low-dose group (82.8% vs 52.5%, respectively; p < 0.001). Approximately 3.4% and 1.6% of patients in the high- and low-dose groups, respectively, had mild transient hypercalcemia, but none developed moderate, severe, or symptomatic hypercalcemia. There were no differences in functional outcome scores between groups.Conclusions: In treatment settings where baseline serum 25(OH)D level can’t be evaluated in older adults with fragility hip fracture, we recommend high-dose vitamin D2 of approximately 60,000 IU/week for 12 weeks, with subsequent switch to a maintenance dose. This regimen effectively restored serum vitamin D to an optimal level in 82.8% of patients without causing symptomatic hypercalcemia.

show abstract

Validity and responsiveness of Barthel index for measuring functional recovery after hemiarthroplasty for femoral neck fracture

Abstract: Since BI was shown to have good validity (moderate to strong correlation with DEMMI and performance-based tests, and mild to moderate correlation with EQ-VAS), BI can be used to accurately assess functional recovery in patients who undergo hemiarthroplasty after femoral neck fracture.

Cited by 46 publications

References 20 publications

High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial

High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial

Use of the pedometer in the evaluation of the effects of rehabilitation treatment on deambulatory autonomy in patients with lower limb arthroplasty during hospital rehabilitation: long-term postoperative outcomes

High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: A randomized controlled trial

Contact Info

Product

Resources

About